Connect your AI

MeiraGTx Holdings plc MGTX Price / sales

Price / sales at other companies

Regeneron PharmaceuticalsREGN

5.5×+0.6×

Opko HealthOPK

1.5×-0.1×

Relay Therapeutics, Inc.RLAY

166.6×+109×

Zevra Therapeutics, Inc.ZVRA

4.5×-5.5×

ALN

Alnylam PharmaceuticalsALNY

10.2×-4.6×

Intellia TherapeuticsNTLA

22.9×+6.8×

Other financials

Income statement

Revenue$293.0K-84.8%

Operating income-$40.8M+1.9%

Net income-$46.3M-15.8%

EPS (diluted)-$0.57-11.8%

Balance sheet

Cash & equivalents$71.5M+7.5%

Total debt$62.7M-22.5%

Total equity-$58.1M-276%

Total assets$244.7M+9.2%

Cash flow

Operating cash flow$17.8M+148%

CapEx$2.0M+17.4%

Free cash flow$15.8M+141%

Valuation

Market cap$1.07B+111%

Enterprise value$1.07B+103%

Profitability

Operating margin-597.9%-207pp

Net margin-615.3%—

FCF margin-441.5%-126pp

Returns & leverage

Return on equity-379.5%—

Debt / equity27.2×+26.1×

Current ratio0.5×-1.0×

Where this comes from

Calculated from MeiraGTx Holdings plc’s reported figures.

market cap/total revenue=8.8×

Based on the most recent quarter.

The official record: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MeiraGTx Holdings plc's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is MeiraGTx Holdings plc's price / sales?: MeiraGTx Holdings plc (MGTX) reported price / sales of 8.8× in Q1 2026.
How has MeiraGTx Holdings plc's price / sales changed year-over-year?: MeiraGTx Holdings plc's price / sales decreased by 42.9% year-over-year, from 15.5× to 8.8×.
What is the long-term trend for MeiraGTx Holdings plc's price / sales?: Over 4 years (2020 to 2025), MeiraGTx Holdings plc's price / sales has grown at a -34.7% compound annual growth rate (CAGR), from 43.2× to 7.9×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.